Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
K. Matthews, C Kamp, N Dalen-Seime, Barbara Kraus et autres
The authors regret .
ie, at, no, mt, pt, fi, gb (code pays fourni par la source)
K. Matthews, C Kamp, N Dalen-Seime, Barbara Kraus et autres
INTRODUCTION: The FORCE initiative, funded by the EU, was created in response to the COVID-19 pandemic's impact on radiography education. It offers a virtual learning environment (VLE) filled with clinical simulation scenarios targeting Diagnostic Imaging, Nuclear Medicine, and Radiotherapy. These scenarios are …
ie, at, no, mt, pt, fi, gb (code pays fourni par la source)
K. Matthews, Ms. Nina Dalen Seime, Prof. Ruth Strudwick, Ms. Gerda Aarhus et autres
ie, no, gb, mt, pt, fi, at (code pays fourni par la source)
Sabrina Fritah, Andrés Cano-Galiano, Réka Tóth, Ann‐Christin Hau et autres
Abstract BACKGROUND Mutations in isocitrate dehydrogenase (IDH) 1 or 2 define glioma classification and determine the biology of these tumors. Although IDH is an essential enzyme in the cellular metabolism, powerful genome-wide analyses focus mostly at the genetic and epigenetic levels, while …
lu, gb, us, no (code pays fourni par la source)
Lars Prestegarden, Agnete Svendsen, Jian Wang, Linda Sleire et autres
Supplementary Figure 1 from Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth
Lars Prestegarden, Agnete Svendsen, Jian Wang, Linda Sleire et autres
Supplementary Figure 2 from Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth
Lars Prestegarden, Agnete Svendsen, Jian Wang, Linda Sleire et autres
Abstract Although CD133 has been proposed as a marker for brain tumor–initiating cells, studies show that a tumorigenic potential exists among CD133− glioma cells as well. However, it is not established whether the ability of CD133− cells to form tumors is a …
Lars Prestegarden, Agnete Svendsen, Jian Wang, Linda Sleire et autres
Supplementary Methods, Figure Legends 1-2 from Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth
Lars Prestegarden, Agnete Svendsen, Jian Wang, Linda Sleire et autres
Abstract Although CD133 has been proposed as a marker for brain tumor–initiating cells, studies show that a tumorigenic potential exists among CD133− glioma cells as well. However, it is not established whether the ability of CD133− cells to form tumors is a …
Lars Prestegarden, Agnete Svendsen, Jian Wang, Linda Sleire et autres
Supplementary Methods, Figure Legends 1-2 from Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth
Lars Prestegarden, Agnete Svendsen, Jian Wang, Linda Sleire et autres
Supplementary Figure 2 from Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth
Lars Prestegarden, Agnete Svendsen, Jian Wang, Linda Sleire et autres
Supplementary Figure 1 from Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.
L'essentiel de l'actu tech du Burkina & d'Afrique, chaque semaine dans votre boîte mail.
Gratuit · sans spam · désinscription en un clic